BusinessAbCellera Announces Successful Completion of Collaboration for the Discovery of Fully Human Antibodies Against Pathogenic E. Coli and Ebola VirusBy Nasdaq OMXJan 21, 2016, 12:14 AM UTC
BusinessCoriell Institute Licenses PluriTest(R), a Novel Stem Cell TechnologyBy Nasdaq OMXJan 20, 2016, 3:09 PM UTC
BusinessAGTC Announces Data Evaluating Novel AAV-Based Gene Therapy as a Potential Treatment for Alpha-1 Antitrypsin (AAT) DeficiencyBy Nasdaq OMXJan 20, 2016, 12:01 PM UTC
BusinessAffimed to Host Hodgkin's Lymphoma Day with Key Opinion Leaders on January 26th in New York CityBy Nasdaq OMXJan 20, 2016, 10:00 AM UTC
BusinessNewLink Genetics Corporation to Present Phase 1b Data on Indoximod in Combination Therapy in Patients With Metastatic Pancreatic Cancer at ASCO GIBy Nasdaq OMXJan 19, 2016, 10:00 PM UTC
BusinessLightlake Therapeutics Inc. Announces Adapt Pharma Limited Facilitates NARCAN® (Naloxone Hydrochloride) Nasal Spray Access to 62,000 State and Local Public EntitiesBy Nasdaq OMXJan 19, 2016, 2:02 PM UTC
BusinessCeva and Zoion Pharma Announce Collaboration to Develop Epithelial Sodium Channel Blockers to Treat Veterinary Ocular Surface DiseasesBy Nasdaq OMXJan 19, 2016, 1:00 PM UTC
BusinessSummit Therapeutics Granted Key European Patent for Novel Antibiotic Ridinilazole for Treatment of C. Difficile InfectionBy Nasdaq OMXJan 19, 2016, 12:00 PM UTC
